XML 27 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)
3 Months Ended 216 Months Ended
Oct. 31, 2013
Oct. 31, 2012
Oct. 31, 2013
Income Statement [Abstract]      
Revenues, net       $ 5,110,784
Cost of Goods Sold       1,620,375
Gross profit       3,490,409
Operating Expenses:      
Research and development 536,174 653,395 134,704,862
Research and development - related party       220,218
Selling and marketing       9,333,214
General and administrative 906,877 1,286,636 152,645,668
General and administrative - related party       314,328
Total Operating Expenses 1,443,051 1,940,031 297,218,290
Operating Loss (1,443,051) (1,940,031) (293,727,881)
Other Income (Expense):      
Miscellaneous income       686,303
Income from assets held for investment, net (Note 11) 193,607 1,042,868 5,773,029
Interest income 23 225 7,782,269
Interest expense (97,772) (117,975) (69,636,676)
Change in fair value of derivative liabilities (Note 10) 1,877,287 358,714 (1,978,949) [1]
Loss on extinguishment of debt       (14,134,068)
Net Income/(Loss) Before Undernoted 530,094 (656,199) (365,235,973)
Minority Interest Share of Loss       3,038,185
Net Income/(Loss) 530,094 (656,199) (362,197,788)
Preferred Stock Dividend    102,297 5,160,694
Net Income/(Loss) Available to Common Stockholders $ 530,094 $ (758,496) $ (367,358,482)
Net Income/(Loss) Per Common Share (Note 8) (in dollars per share)      
Basic $ 0.001 $ (0.002)  
Diluted $ 0.001 $ (0.002)  
Shares Used to Compute Earnings/(Loss) per Share (Note 8)      
Basic 584,122,030 364,310,359  
Diluted 650,503,975 364,310,359  
[1] Includes $5,981,403 as adjustment related to the adoption of FASB ASC Topic 815 in "Cumulative from November 2, 1995